Jerome Cambre - Jan 17, 2023 Form 4/A - Amendment Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role
Vice President of Sales
Signature
/s/ Jesse Bergeron, Attorney-in-Fact
Stock symbol
VMD
Transactions as of
Jan 17, 2023
Transactions value $
-$36,643
Form type
4/A - Amendment
Date filed
1/20/2023, 04:18 PM
Date Of Original Report
Jan 18, 2023
Previous filing
May 10, 2022
Next filing
May 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VMD Common Shares Options Exercise +3K +4.78% 65.8K Jan 18, 2023 Direct F1
transaction VMD Common Shares Disposed to Issuer -$23.3K -3K -4.56% $7.77 62.8K Jan 18, 2023 Direct F2
transaction VMD Common Shares Options Exercise +4.81K +7.65% 67.6K Jan 18, 2023 Direct F3
transaction VMD Common Shares Tax liability -$13.3K -1.71K -2.53% $7.77 65.9K Jan 18, 2023 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VMD Phantom Share Units Options Exercise $0 -3K -33.33% $0.00 6.01K Jan 18, 2023 Common Shares 3K Direct F1, F5
transaction VMD Restricted Stock Units Options Exercise $0 -4.81K -33.34% $0.00 9.61K Jan 18, 2023 Common Shares 4.81K Direct F3, F6
transaction VMD Phantom Share Units Award $0 +6.39K $0.00 6.39K Jan 17, 2023 Common Shares 6.39K Direct F7, F8
transaction VMD Restricted Stock Units Award $0 +25.6K $0.00 25.6K Jan 17, 2023 Common Shares 25.6K Direct F3, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F2 Per share value is based on the market closing price of the common shares for January 18, 2023.
F3 Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F4 On January 18, 2023, the reporting person filed a timely Form 4 which omitted the withholding of shares to satisfy tax obligations due to timing differences in the processing of awards. This amendment includes the timely reporting of tax related withholding of shares associated with vestings of awards previously reported on this form.
F5 Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
F6 Restricted Stock Units (RSUs) granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F7 Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
F8 Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
F9 Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

Exhibit List: -Exhibit 24 Limited Power of Attorney